WEBULL
WebtradeDownload

LIXIL (TSE:5938) Revenue Growth Contrasts With A Widening Quarterly Loss

Simply Wall St · 1d ago

LIXIL stock went into this earnings print under pressure, down about 4% over the past week and 5% over the past month, even as the 90 day return stayed slightly positive. The market has been paying up for the story, with a trailing P/E around 90x and the share price more than double a discounted cash flow estimate of ¥848.97.

Today’s Q1 headline is simple and uncomfortable. Revenue reached ¥379.2b, yet LIXIL booked a quarterly loss of ¥3.5b and management still held full year core earnings guidance at ¥45.0b. That gap between rich valuation and profit squeeze now sits front and center for investors.

Love the premium LIXIL valuation but concerned about the current profit squeeze and quarterly loss? Check out our list of solid balance sheet and fundamentals stocks (38 results) as a benchmark for stocks where pricing power is supported by sturdier fundamentals.

Q1 2027 Earnings Summary

  • Revenue (Q1 2027 vs. Q1 2026): ¥379,212m vs. ¥364,680m (up about 4%)
  • Net Loss (Q1 2027 vs. Q1 2026): ¥3,507m loss vs. ¥909m loss (loss widened by about 2.9x)
  • Basic EPS (Q1 2027 vs. Q1 2026): ¥12.20 loss per share vs. ¥3.16 loss per share (loss per share increased by about 3.9x)
  • Core Earnings (Q1 2027): ¥1,700m, with LIXIL highlighting cost pressures and timing lags on price revisions

Prefer clear visuals instead of another wall of earnings tables and raw figures? Get a full picture of LIXIL’s current valuation setup in an easy dashboard format with the company report for LIXIL.

TSE:5938 Trailing 12-Month Revenue & Expenses Breakdown as at Aug 2026
TSE:5938 Trailing 12-Month Revenue & Expenses Breakdown as at Aug 2026

LIXIL Bull Case Meets Mixed Early Evidence

The bullish story on LIXIL centers on a pivot to higher margin premium products, cleaner portfolios and stronger cash generation to fund global expansion. This quarter gives partial but incomplete proof. Revenue reached ¥379.2b and management kept the full year core earnings target of ¥45.0b. That signals confidence that price hikes and cost cuts can offset raw material and logistics pressure later in the year. Recent moves in IMEA, such as the GROHE SPA showrooms and water experience center, line up with the push into premium, design led and sustainability focused offerings. The new American Standard distribution deal in Australia and prior IMEA driven core earnings growth also support the idea of broadening premium reach.

At the same time, Q1 core earnings of ¥1.7b and a quarterly loss of ¥3.5b show that margin recovery and stronger free cash flow are still ahead rather than already achieved.

Reveal where the surface looks calm but the multi year models start to disagree by accessing the full revenue, EPS and cash flow analyst estimates for LIXIL.

LIXIL Bear Case Finds Fresh Support In Q1 Misses

The bearish view on LIXIL argues that a shrinking domestic housing market, cost inflation and slow execution could keep margins weak for longer. This quarter gives that view more support than relief. Revenue of ¥379.2b was not the problem. The issue is a quarterly loss of ¥3.5b and core earnings of only ¥1.7b while renovation demand softened and raw material and logistics costs bit harder. That is exactly the kind of margin squeeze bears have warned about.

Execution risk also looks real. Management is holding a ¥45.0b core earnings target and dividend guidance. Yet the earnings call confirmed price revisions only start to land from July through October, and renovation mix actually went the wrong way as new housing was prioritized. International growth initiatives in IMEA and Australia are progressing, but in this quarter they did not offset weaker profitability or the domestic demand and cost headwinds that underpin the cautious narrative.

With LIXIL reporting losses, pressured core earnings and a dividend that is not well covered, it may be worth asking whether these issues are isolated or part of a deeper pattern. Scan the independent risk analysis for LIXIL which shows 3 important warning signs to see if other structural warning signs are already visible in the data.

Stay Ahead With Your LIXIL View

If the mix of rich valuation, Q1 loss and future margin questions around LIXIL has your attention, register for free with Simply Wall St and add it to a Watchlist to watch how the share price tracks against fair value before deciding on an entry point. After you own any stocks, use the Portfolio Command Center to keep a tight focus on essential updates instead of day to day noise. For a longer term edge, compare your thesis against other investors through the Community and see how sentiment shifts as new data arrives. By spotting potential catalysts and risks early, you give yourself a better chance of staying ahead of the market.

Seeking Alternatives Beyond LIXIL Now

Fresh stock ideas can start to move before you notice the breakout. Do not get caught watching momentum fly without you. Scan these under the radar picks and act now.

  • Spot dependable income ideas before yields drop by reviewing the curated 42 dividend fortresses that filters for companies aiming to combine strong payouts with sturdier balance sheets.
  • Track early momentum in companies building the digital rails for tomorrow with the focused 55 AI infrastructure stocks that highlights businesses tied to the backbone of AI growth.
  • Catch potential upside in companies tied to global electrification trends using the curated 8 top copper producer stocks that concentrates on producers linked to long term copper demand themes.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.